SCHEMBL15040985

SCHEMBL15040985

Cc1ccc(C(=O)c2ccc3ccccc3c2)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.61
LMNA P02545 1/20 0.61
CES2 O00748 1/20 0.59
CES1 P23141 1/20 0.59
NPC1 O15118 4/20 0.58
RAB9A P51151 4/20 0.58
ACHE P22303 1/20 0.58
MEN1 O00255 2/20 0.58
KMT2A Q03164 2/20 0.58
HSD17B14 Q9BPX1 1/20 0.57
HPGD P15428 3/20 0.54
SMN1; SMN2 Q16637 3/20 0.54
MAPT P10636 2/20 0.54
CYP2A6 P11509 2/20 0.54
TDP1 Q9NUW8 2/20 0.54
SRD5A2 P31213 1/20 0.53
CLK1 P49759 1/20 0.53
DYRK1A Q13627 1/20 0.53
DYRK1B Q9Y463 1/20 0.53
KDM4E B2RXH2 2/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21230327 0.92 ALDH1A1 (0.73) ALDH1A1LMNACES2CES1NPC1
SCHEMBL13674375 0.90 NPC1 (0.50) ALDH1A1LMNACES2CES1NPC1
SCHEMBL941698 0.88 CES2 (0.74) ALDH1A1CES2CES1NPC1RAB9A
SCHEMBL29613672 0.88 CES2 (0.74) ALDH1A1CES2CES1NPC1RAB9A
SCHEMBL30250451 0.88 CES2 (0.74) ALDH1A1CES2CES1NPC1RAB9A
SCHEMBL14036119 0.87 RAB9A (0.66) ALDH1A1LMNACES2CES1NPC1
SCHEMBL29834246 0.86 MEN1 (0.75) ALDH1A1CES2CES1NPC1RAB9A
SCHEMBL124894 0.86 MEN1 (0.75) ALDH1A1CES2CES1NPC1RAB9A
Hydrochloric Acid SCHEMBL27733605 0.86 CES2 (0.71) ALDH1A1CES2CES1NPC1RAB9A
SCHEMBL27826301 0.86 CES2 (0.71) ALDH1A1CES2CES1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10403833-B2 Organic metal complexes MERCK PATENT GMBH (DE) 2019-09-03 US disclosed
US-9879177-B2 Metal complexes comprising condensed heteroaromatic rings MERCK PATENT GMBH (DE) 2018-01-30 US disclosed
US-9879177-B2 Metal complexes comprising condensed heteroaromatic rings MERCK PATENT GMBH (DE) 2018-01-30 US disclosed
US-20170317298-A1 ORGANIC METAL COMPLEXES UDC IRELAND LIMITED (IE) 2017-11-02 US disclosed
US-20170317298-A1 ORGANIC METAL COMPLEXES UDC IRELAND LIMITED (IE) 2017-11-02 US disclosed
US-9748502-B2 Organic metal complexes MERCK PATENT GMBH (DE) 2017-08-29 US disclosed
US-9748502-B2 Organic metal complexes MERCK PATENT GMBH (DE) 2017-08-29 US disclosed
EP-2791275-B1 ORGANIC SENSITIZERS FOR UP-CONVERSION MERCK PATENT GMBH (DE) 2017-05-31 EP disclosed
EP-2797940-B1 METAL COMPLEXES COMPRISING 1,2,3-TRIAZOLES MERCK PATENT GMBH (DE) 2016-02-24 EP disclosed
US-20150105843-A1 METAL COMPLEXES COMPRISING CONDENSED HETEROAROMATIC RINGS UDC IRELAND LIMITED (IE) 2015-04-16 US disclosed
US-20140371825-A1 ORGANIC METAL COMPLEXES UDC IRELAND LIMITED (IE) 2014-12-18 US disclosed
US-20140371825-A1 ORGANIC METAL COMPLEXES UDC IRELAND LIMITED (IE) 2014-12-18 US disclosed
US-20140358198-A1 ORGANIC SENSITIZERS FOR UP-CONVERSION MERCK PATENT GMBH (DE) 2014-12-04 US disclosed
US-20140358198-A1 ORGANIC SENSITIZERS FOR UP-CONVERSION MERCK PATENT GMBH (DE) 2014-12-04 US disclosed
US-20140350642-A1 Metal Complexes Comprising 1,2,3-Triazoles MERCK PATENT GMBH (DE) 2014-11-27 US disclosed
US-20140350642-A1 Metal Complexes Comprising 1,2,3-Triazoles MERCK PATENT GMBH (DE) 2014-11-27 US disclosed
WO-2013174471-A1 METAL COMPLEXES COMPRISING CONDENSED HETEROAROMATIC RINGS MERCK PATENT GMBH (DE) 2013-11-28 WO disclosed
WO-2013107487-A1 ORGANIC METAL COMPLEXES MERCK PATENT GMBH (DE) 2013-07-25 WO disclosed
WO-2013097920-A1 METAL COMPLEXES COMPRISING 1,2,3-TRIAZOLES MERCK PATENT GMBH (DE) 2013-07-04 WO disclosed
WO-2013087162-A1 ORGANIC SENSITIZERS FOR UP-CONVERSION MERCK PATENT GMBH (DE) 2013-06-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10403833-B2 Organic metal complexes SOD1, ORC3, PPIA ALDH1A1 2269/4885LMNA 4251/4885CES2 2420/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.